OPKO HEALTH INC. - CO

OPKO Health to Report Second Quarter 2021 Financial Results on July 29, 2021

20 июл 2021 08:00:02 Источник Nasdaq GlobeNewswire

OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics

12 июл 2021 08:00:01 Источник Nasdaq GlobeNewswire

OPKO Health to Present at the Ladenburg Thalmann Healthcare Conference

08 июл 2021 16:05:00 Источник Nasdaq GlobeNewswire

OPKO Health Appoints Katherine Stueland as President and CEO of GeneDx

22 июн 2021 08:00:00 Источник Nasdaq GlobeNewswire

OPKO Health to Develop and Commercialize RAYALDEE® in Greater China with Nicoya Therapeutics

21 июн 2021 08:03:07 Источник Nasdaq GlobeNewswire

OPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland

17 июн 2021 07:00:00 Источник Nasdaq GlobeNewswire

OPKO Health to Participate in the Jefferies Virtual Healthcare Conference

27 май 2021 08:30:01 Источник Nasdaq GlobeNewswire

OPKO Health Reports Transfer of Licensed Rights to RAYALDEE® in Japan to Vifor

24 май 2021 07:30:00 Источник Nasdaq GlobeNewswire

OPKO Health Enters into Exchange Agreements with Certain 4.5% Convertible Senior Noteholders

07 май 2021 13:33:56 Источник Nasdaq GlobeNewswire

OPKO Health to Report First Quarter 2021 Financial Results on April 28, 2021

22 апр 2021 08:00:01 Источник Nasdaq GlobeNewswire

OPKO Health Reports 2020 Fourth Quarter Business Highlights and Financial Results

18 фев 2021 16:05:01 Источник Nasdaq GlobeNewswire

OPKO Health to Report Fourth Quarter 2020 Financial Results on February 18, 2021

03 фев 2021 09:01:22 Источник Nasdaq GlobeNewswire

New Drug Application Submitted to PMDA in Japan for Somatrogon, to Treat Pediatric Patients with Growth Hormone Deficiency

28 янв 2021 08:00:01 Источник Nasdaq GlobeNewswire

OPKO Health to Present at the 39th Annual J.P. Morgan Healthcare Conference

05 янв 2021 08:00:01 Источник Nasdaq GlobeNewswire